Christian Pfrepper/ResearchGate
Oct 3, 2025, 12:40
Christian Pfrepper and Team’s Letter on Emicizumab Plasma Concentration Measurment in EDTA plasma
RPTH Journal shared on LinkedIn:
”It’s mail day here at RPTH Journal
Check out this Research Letter from Christian Pfrepper and team showing that Emicizumab plasma concentration can be measured in EDTA plasma without relevant influence of residual FVIII.”
Read the full article here.
Article: Assessment of emicizumab levels in EDTA plasma
Authors: Christian Pfrepper, Annelie Siegemund, Tristan Klöter, Hagen Bönigk, Sirak Petros, Thomas Siegemund
Stay updated on all scientific advances in the field of hemophilia with Hemostasis Today.
-
Dec 15, 2025, 15:58Khaled Musallam Applauds Hatoon Ezzat’s Leadership and Healthcare Advances in Saudi Arabia
-
Dec 15, 2025, 12:46Deborah Ebert Long on Hemophilia Care: Progress, Possibility, and the Power of Listening
-
Dec 15, 2025, 12:34Nathan Connell on Conversion from Eptacog Alfa to Beta
-
Dec 15, 2025, 12:17Danny Hsu on Interdisciplinary Toolkit for Gynecologic Bleeding on Anticoagulation
-
Dec 15, 2025, 12:08Ted Roh: A Historic Milestone for Indonesia’s Health Innovation
-
Dec 15, 2025, 11:28Wolfgang Miesbach Shares Insights from Davide Matino’s Presentation on Marstacimab at ASH25
-
Dec 15, 2025, 11:12Tushar Pandey Awarded for His Enourmous Contribution to Hematology
-
Dec 15, 2025, 11:07DISTRO: Vidya Rajbhoj on AI and Digital Technology to Improve Stroke Rehabilitation
-
Dec 15, 2025, 11:00Ischemic Stroke, AF and Atherosclerotis: Amira Khater on Sufficiency of Anticoagulant Monotherapy